GSK3B and breast cancer: Recent findings show that PI3K signaling enhances Wnt/β-catenin signaling in ER+ breast cancer by promoting GSK3β lysosomal degradation, but paradoxically suppresses Wnt/β-catenin activation in ER− breast cancer by unknown mechanisms.